MedTrace Logo

Glucose Regulation in Acute Stroke Patients (GRASP) Study

NCT00282867 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2009-08-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the feasibility, safety and preliminary efficacy of the use of insulin infusions as treatment for hyperglycemic acute ischemic stroke patients.

Conditions

Interventions

DRUG

IV glucose insulin and potassium, GIK

The treatment intervention includes glucose, insulin, potassium infusion or standard therapy.

OTHER

standard care

usual care

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of Virginia

    lead OTHER

Principal Investigators

  • Karen Johnston, MD · University of Virginia, Department of Neurology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2008-02-29
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282867 on ClinicalTrials.gov